These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 3534756)
1. [Comparative activity in vitro of ceftizoxime, ceftazidime and imipenem against Acinetobacter calcoaceticus]. Joly-Guillou ML; Bergogne-Bérézin E Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):625-8. PubMed ID: 3534756 [TBL] [Abstract][Full Text] [Related]
2. [In vitro activity of ceftazidime compared with five beta-lactamase stable compounds against clinical strains of Acinetobacter calcoaceticus ]. Bergogne-Berezin E; Joly-Guillou ML; Verin-Prevost C Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):506-9. PubMed ID: 6289227 [TBL] [Abstract][Full Text] [Related]
3. Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus. Bergogne-Berezin E; Joly-Guillou ML J Antimicrob Chemother; 1986 Dec; 18 Suppl E():35-9. PubMed ID: 3546246 [TBL] [Abstract][Full Text] [Related]
4. [Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776]. Joly-Guillou ML; Serieys C; Verin-Prevost C; Bergogne-Berezin E Pathol Biol (Paris); 1983 May; 31(5):392-5. PubMed ID: 6353329 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of antimicrobial agents against Acinetobacter calcoaceticus. Joly-Guillou ML; Bergogne-Berezin E Drugs Exp Clin Res; 1986; 12(12):949-52. PubMed ID: 3471431 [TBL] [Abstract][Full Text] [Related]
6. [Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus]. Vallée E; Joly-Guillou ML; Bergogne-Berezin E Presse Med; 1990 Apr; 19(13):588-91. PubMed ID: 2139937 [TBL] [Abstract][Full Text] [Related]
7. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus]. Joly-Guillou ML; Bergogne-Berezin E Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin. Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728 [TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin. Chin NX; Neu HC Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967 [TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii]. Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group. Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641 [TBL] [Abstract][Full Text] [Related]
12. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates]. López-Hernández S; Alarcón T; López-Brea M Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706 [TBL] [Abstract][Full Text] [Related]
13. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime]. Le Noc P; Bryskier A; Le Noc D Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396 [TBL] [Abstract][Full Text] [Related]
14. Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004. Unal S; Garcia-Rodriguez JA Diagn Microbiol Infect Dis; 2005 Dec; 53(4):265-71. PubMed ID: 16360550 [TBL] [Abstract][Full Text] [Related]
15. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli]. Thabaut A; Meyran M; Huerre M Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217 [TBL] [Abstract][Full Text] [Related]
16. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup. Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272 [TBL] [Abstract][Full Text] [Related]
17. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer]. Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K Cas Lek Cesk; 1997 Mar; 136(5):154-6. PubMed ID: 9221190 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of imipenem towards gram-negative bacilli. Speciale A; Caccamo F; Pellegrino MB; Blandino G; Nicoletti G Chemioterapia; 1986 Oct; 5(5):291-6. PubMed ID: 3466723 [TBL] [Abstract][Full Text] [Related]
19. Antibacterial properties of imipenem with special reference to the activity against methicillin-resistant staphylococci, cefotaxime-resistant Enterobacteriaceae and Pseudomonas aeruginosa. Vurma-Rapp U; Kayser FH; Barberis-Maino L J Antimicrob Chemother; 1986 Dec; 18 Suppl E():27-33. PubMed ID: 3102452 [TBL] [Abstract][Full Text] [Related]
20. [Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals]. Babálová M; Krălíková K; Krcméry V; Kubonová K Cas Lek Cesk; 1996 Mar; 135(6):181-4. PubMed ID: 8681362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]